← Insider buys
RETA

Reata Pharmaceuticals Inc

Chief Commercial Officer Dawn Carter Bir sold $9.8M of Reata Pharmaceuticals Inc

Sold$9,750,300
$162.51Price
60,000Shares
−100%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Mon, Nov 9. Filed Tue, Nov 10, 12:30 PM ET, during the session. Not investment advice.